PRESS RELEASE published on 12/02/2024 at 19:00, 1 year ago Inside Information / Other news releases Claranova (Euronext Paris: FR0013426004 - CLA) releases 2025 financial calendar. Dates include revenue and results announcements. Company aims for growth and profitability Revenue Financial Calendar Growth Results Claranova
BRIEF published on 11/15/2024 at 08:05, 1 year ago Claranova at the Investir Day 2024 trade fair Shareholders Technological Innovation Strategy Claranova Invest Day
BRIEF published on 11/13/2024 at 18:05, 1 year ago Claranova Reports Stable Revenue Amid Strategic Shifts Claranova PlanetArt Q1 Revenue Avanquest MyDevices Sale
PRESS RELEASE published on 11/13/2024 at 18:00, 1 year ago Inside Information / Other news releases Claranova reports Q1 2024-2025 revenue of €89m with stable like-for-like performance, while focusing on core businesses and profitability targets Profitability Targets Claranova Core Businesses Q1 Revenue Like-for-like Performance
BRIEF published on 11/11/2024 at 18:05, 1 year ago Claranova completes the acquisition of PlanetArt’s minority stakes Strategy Redemption Synergies Claranova PlanetArt
PRESS RELEASE published on 11/11/2024 at 18:00, 1 year ago Inside Information / Other news releases Claranova announces buyout of all PlanetArt minority interests, implementing 'One Claranova' strategy. Transaction amount: €18.5m financed by borrowing, buyout price 40% lower than 2022 agreement Acquisition Strategy Claranova PlanetArt Buyout
BRIEF published on 11/05/2024 at 21:05, 1 year ago Claranova: Publication of the Number of Voting Rights and Shares Share Capital Voting Rights Actions Regulation Claranova
BRIEF published on 10/31/2024 at 20:36, 1 year 1 month ago Claranova publishes its 2023-2024 Universal Registration Document Financial Report Financial Agenda General Meeting Consolidated Accounts Claranova
PRESS RELEASE published on 10/31/2024 at 20:31, 1 year 1 month ago Annual financial and audit reports / Terms of availability of the annual financial report Claranova announces availability of FY 2023-2024 Universal Registration Document including annual financial report. Consolidated financial statements approved and certified Consolidated Financial Statements Financial Report Universal Registration Document FY 2023-2024 Claranova
BRIEF published on 10/30/2024 at 20:05, 1 year 1 month ago Claranova announces its General Meeting for December 2024 Financial Results Shareholders General Assembly Claranova Online Voting
Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 53 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
